|
[1]
|
王逸群, 熊辉, 郑波. T淋巴细胞计数与严重肺炎患者的相关性分析[J]. 中华医院感染学杂志, 2014, 24(21): 5330-5332.
|
|
[2]
|
曾廷武, 杜飞. 淋巴细胞和中性粒细胞计数对严重社区获得性肺炎死亡风险的影响[J]. 中国老年学杂志, 2021, 41(16): 3423-3426.
|
|
[3]
|
Vadi, S., Sanwalka, N., Pednekar, A., Suthar, D., Ghodke, K. and Rabade, N. (2022) Association of Mortality with Lymphocyte Subset in Patients with Covid-19-Associated Acute Respiratory Failure: A Subgroup Analysis. Indian Journal of Critical Care Medicine, 27, 52-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
黄卫东, 徐庆十, 刘纯义, 等. 小儿重症肺炎淋巴细胞凋亡与CD11b的表达[J]. 中国妇幼保健, 2007(30): 4329-4331.
|
|
[5]
|
张添威, 郭微微, 张蓉映, 等. 动态监测血清CRP对指导重症肺炎患者临床用药的意义及联合IL-8、Th1对预后预警的价值[J]. 广东医学, 2021, 42(3): 283-287.
|
|
[6]
|
刘守娟, 方喜波, 王志华, 等. 小儿肺炎不同感染病原体类型外周血WBC和血清CRP、PCT水平特点及其相关性研究[J]. 临床和实验医学杂志, 2021, 20(6): 667-670.
|
|
[7]
|
胡志德, 韩志君, 孙懿, 等. C反应蛋白对重症社区获得性肺炎患者住院期间死亡的预测价值[J]. 第二军医大学学报, 2012, 33(5): 501-505.
|
|
[8]
|
李娜, 刘婧, 苗晓云, 等. C反应蛋白与白蛋白比值预测重症肺炎患者预后的临床研究[J]. 临床肺科杂志, 2017, 22(6): 1113-1116.
|
|
[9]
|
冯开俊, 张泓. 血小板相关参数联合肺炎严重指数评分对重症肺炎患者病死率的预测作用[J]. 中国急救医学, 2019, 39(8): 739-743.
|
|
[10]
|
邵婷婷. 各血小板参数检测联合肺炎严重指数评分在重症肺炎患者中的死亡率预测作用分析[J]. 中国卫生检验杂志, 2020, 30(4): 402-404+407.
|
|
[11]
|
潘美靖, 秦泽鸿, 翁锡泉. 血小板参数在评估感染相关性血小板减少症预后的价值[J]. 血栓与止血学, 2016, 22(1): 85-87.
|
|
[12]
|
姜迎厚, 王瑛, 韩云宏. NLR评估老年重症肺炎严重程度及预后的价值[J]. 临床肺科杂志, 2018, 23(12): 2170-2174.
|
|
[13]
|
Regolo, M., Vaccaro, M., Sorce, A., Stancanelli, B., Colaci, M., Natoli, G., et al. (2022) Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients. Journal of Clinical Medicine, 11, Article No. 2235. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., et al. (2020) Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, 71, 762-768. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Simon, P., Le Borgne, P., Lefevbre, F., Cipolat, L., Remillon, A., Dib, C., et al. (2022) Platelet-to-Lymphocyte Ratio (PLR) Is Not a Predicting Marker of Severity but of Mortality in COVID-19 Patients Admitted to the Emergency Department: A Retrospective Multicenter Study. Journal of Clinical Medicine, 11, Article No. 4903. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
李萌, 姚莉, 王菁, 等. NLR PLR在评估重症肺炎患者预后中的价值[J]. 安徽医学, 2020, 41(4): 463-466.
|
|
[17]
|
惠晓霞, 王琪, 张文乾. 重症肺炎患儿血清IL-1R1、APC、sICAM-1、NLR及PLR的变化及其临床意义[J]. 实验与检验医学, 2019, 37(3): 465-467+495.
|
|
[18]
|
Zhang, J., Gao, Y., Wang, X., Li, N., Du, X., Tang, Y., et al. (2022) Lymphocyte-C-Reactive Protein Ratio Can Differentiate Disease Severity of COVID-19 Patients and Serve as an Assistant Screening Tool for Hospital and ICU Admission. Frontiers in Immunology, 13, Article ID: 957407. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Liu, X. and Mu, Y. (2023) Lymphocyte to C-Reactive Protein Ratio as an Early Biomarker to Distinguish Sepsis from Pneumonia in Neonates. Journal of Inflammation Research, 16, 3509-3517. [Google Scholar] [CrossRef] [PubMed]
|